Alzheimer’s and Blood Glucose Levels Study
The Alzheimer’s and Blood Glucose Levels Study is researching the differences in blood glucose levels between people with and without Mild Cognitive Impairment or Alzheimer’s disease, with the aim of early detection of Alzheimer’s disease.
This study will collect continuous glucose monitor (CGM) data from participants already using CGMs to better understand the relationship between Alzheimer’s disease and blood glucose levels. This study will use the Endobits Companion app for data collection. The Endobits Companion app is freely available for Android and iOS mobile devices, and was designed to keep track as a data entry app for patients to connect with their physicians.
Due to the current COVID-19 pandemic, this study is fully online.
The study is listed on the Alzheimer’s Prevention Registry, and you can learn more about it here.
The information sheet for the study is available here.
You may be eligible for the Alzheimer’s and Blood Glucose Levels Study if you meet the following criteria:
Are ≥ 50 years old, and
Currently use a continuous glucose monitor, and will continue to use it for the next 90 days
To enroll in the study, download the Endobits Companion app using the links below to get started.